Edwards Earnings per Diluted Share vs Earnings per Basic Share Analysis

EW Stock  USD 95.15  1.73  1.85%   
Trend analysis of Edwards Lifesciences Corp balance sheet accounts such as Total Current Liabilities of 1.3 B provides information on Edwards Lifesciences' total assets, liabilities, and equity, which is the actual value of Edwards Lifesciences Corp to its prevalent stockholders. By breaking down trends over time using Edwards Lifesciences balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

About Edwards Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Edwards Lifesciences Corp at a specified time, usually calculated after every quarter, six months, or one year. Edwards Lifesciences Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Edwards Lifesciences and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Edwards currently owns. An asset can also be divided into two categories, current and non-current.

Edwards Lifesciences Balance Sheet Chart

Edwards Lifesciences Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Edwards Lifesciences Corp uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Edwards Lifesciences' Liabilities And Stockholders Equity is fairly stable compared to the past year. Inventory is likely to climb to about 1.2 B in 2024, whereas Good Will is likely to drop slightly above 688.6 M in 2024.

Total Assets

Total assets refers to the total amount of Edwards Lifesciences assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Edwards Lifesciences Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Edwards Lifesciences balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Edwards Lifesciences Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Common Stock Total Equity

The total value of common stock equity held by shareholders, representing their ownership interest in the company.
Most indicators from Edwards Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
Selling General Administrative is likely to climb to about 1.8 B in 2024, whereas Tax Provision is likely to drop slightly above 201.8 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit4.0B4.3B4.6B4.9B
Total Revenue5.2B5.4B6.0B6.3B

Edwards Lifesciences fundamental ratios Correlations

-0.450.880.990.970.920.990.80.810.970.7-0.910.720.960.98-0.630.760.940.960.480.93-0.680.730.850.810.4
-0.45-0.43-0.48-0.48-0.37-0.46-0.4-0.31-0.41-0.340.32-0.13-0.45-0.450.14-0.23-0.5-0.41-0.14-0.410.31-0.51-0.36-0.420.18
0.88-0.430.820.80.690.870.650.740.850.74-0.80.680.850.82-0.340.810.770.850.610.91-0.470.610.770.640.25
0.99-0.480.820.990.950.980.840.750.970.66-0.90.630.970.97-0.690.670.970.940.370.87-0.680.750.790.810.34
0.97-0.480.80.990.930.980.80.710.970.67-0.860.640.960.97-0.660.670.960.910.320.87-0.70.780.770.840.31
0.92-0.370.690.950.930.890.930.730.930.45-0.870.520.930.91-0.870.530.960.910.270.73-0.660.580.730.790.35
0.99-0.460.870.980.980.890.770.720.950.76-0.870.70.940.95-0.580.750.920.90.460.92-0.610.80.790.790.36
0.8-0.40.650.840.80.930.770.610.830.33-0.80.290.880.74-0.860.350.910.810.190.58-0.540.440.620.740.16
0.81-0.310.740.750.710.730.720.610.760.42-0.830.780.720.84-0.550.750.680.920.630.8-0.690.320.930.630.61
0.97-0.410.850.970.970.930.950.830.760.61-0.880.630.980.95-0.670.680.960.950.320.87-0.750.670.820.790.28
0.7-0.340.740.660.670.450.760.330.420.61-0.520.720.630.63-0.040.810.550.560.60.79-0.350.880.590.530.37
-0.910.32-0.8-0.9-0.86-0.87-0.87-0.8-0.83-0.88-0.52-0.59-0.9-0.890.62-0.59-0.88-0.93-0.48-0.830.62-0.52-0.85-0.75-0.46
0.72-0.130.680.630.640.520.70.290.780.630.72-0.590.570.73-0.270.960.480.720.760.85-0.560.540.820.590.74
0.96-0.450.850.970.960.930.940.880.720.980.63-0.90.570.93-0.680.630.980.930.330.85-0.690.690.790.840.26
0.98-0.450.820.970.970.910.950.740.840.950.63-0.890.730.93-0.640.740.920.960.410.91-0.750.690.860.810.41
-0.630.14-0.34-0.69-0.66-0.87-0.58-0.86-0.55-0.67-0.040.62-0.27-0.68-0.64-0.22-0.74-0.67-0.05-0.370.51-0.23-0.48-0.64-0.3
0.76-0.230.810.670.670.530.750.350.750.680.81-0.590.960.630.74-0.220.530.740.780.88-0.50.610.790.580.6
0.94-0.50.770.970.960.960.920.910.680.960.55-0.880.480.980.92-0.740.530.910.230.78-0.690.680.740.820.22
0.96-0.410.850.940.910.910.90.810.920.950.56-0.930.720.930.96-0.670.740.910.480.89-0.760.550.920.790.44
0.48-0.140.610.370.320.270.460.190.630.320.6-0.480.760.330.41-0.050.780.230.480.61-0.060.310.610.320.74
0.93-0.410.910.870.870.730.920.580.80.870.79-0.830.850.850.91-0.370.880.780.890.61-0.670.710.890.80.44
-0.680.31-0.47-0.68-0.7-0.66-0.61-0.54-0.69-0.75-0.350.62-0.56-0.69-0.750.51-0.5-0.69-0.76-0.06-0.67-0.44-0.8-0.68-0.26
0.73-0.510.610.750.780.580.80.440.320.670.88-0.520.540.690.69-0.230.610.680.550.310.71-0.440.510.620.21
0.85-0.360.770.790.770.730.790.620.930.820.59-0.850.820.790.86-0.480.790.740.920.610.89-0.80.510.750.6
0.81-0.420.640.810.840.790.790.740.630.790.53-0.750.590.840.81-0.640.580.820.790.320.8-0.680.620.750.31
0.40.180.250.340.310.350.360.160.610.280.37-0.460.740.260.41-0.30.60.220.440.740.44-0.260.210.60.31
Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets6.5B7.2B8.5B8.3B9.4B9.8B
Other Current Liab6.4M39.3M3.9M311M15.2M14.4M
Total Current Liabilities902.4M893.9M1.0B1.0B1.2B1.3B
Total Stockholder Equity4.1B4.6B5.8B5.8B6.7B7.0B
Property Plant And Equipment Net1.1B1.5B1.6B1.7B1.8B1.9B
Retained Earnings3.7B4.6B6.1B7.6B9.0B9.4B
Non Current Assets Total3.5B4.1B5.3B5.2B5.3B5.6B
Non Currrent Assets Other101.8M119.6M110.8M299.1M463.7M486.9M
Cash And Short Term Investments1.5B1.4B1.5B1.2B1.6B1.7B
Net Receivables599.1M602.8M664.9M699.1M836.9M878.7M
Good Will1.2B1.2B1.2B1.2B1.3B688.6M
Common Stock Shares Outstanding636.7M631.9M631.2M624.2M609.4M550.8M
Liabilities And Stockholders Equity6.5B7.2B8.5B8.3B9.4B9.8B
Non Current Liabilities Total1.4B1.8B1.6B1.5B1.4B800.7M
Inventory640.9M802.3M726.7M875.5M1.2B1.2B
Other Current Assets168M208.2M237.1M195.9M239.3M251.3M
Other Stockholder Equity344.6M(466M)(716.5M)(2.2B)(2.8B)(2.6B)
Total Liab2.3B2.7B2.7B2.5B2.6B1.4B
Property Plant And Equipment Gross1.1B1.5B1.6B1.7B2.7B2.8B
Total Current Assets3.0B3.1B3.2B3.1B4.0B4.2B
Accumulated Other Comprehensive Income(156M)(161.1M)(157.7M)(254.9M)(242.8M)(230.7M)
Short Long Term Debt Total593.8M678.8M694.9M690.3M691.3M486.4M
Other Liab784.1M1.1B969.6M797.6M917.2M963.1M
Net Debt(500.3M)(488.3M)(172.5M)(77.7M)(449.1M)(426.6M)
Accounts Payable180.4M196.5M204.5M201.9M201.4M139.5M
Cash1.2B1.2B862.8M769M1.1B1.2B
Other Assets274M1.2B357.5M783.1M900.6M945.6M
Long Term Debt594.4M595M595.7M596.3M597M425.6M
Common Stock Total Equity218.1M636.4M642M646.3M743.2M780.4M
Short Term Debt598M0.025.5M27.2M24.9M23.7M
Intangible Assets336.5M331.4M323.6M285.2M428.4M449.8M
Common Stock218.1M636.4M642M646.3M650.5M683.0M
Property Plant Equipment1.1B1.4B1.6B1.7B2.0B2.1B
Treasury Stock(1.0B)(1.3B)(1.9B)(2.4B)(2.2B)(2.1B)
Short Term Investments337.8M219.4M604M446.3M500.5M382.6M
Net Tangible Assets2.9B3.4B4.3B4.4B5.0B5.3B
Retained Earnings Total Equity3.7B4.6B6.1B7.6B8.7B9.2B
Capital Surpluse1.6B1.4B1.7B2.0B2.3B1.2B
Long Term Investments585.5M801.6M1.8B1.2B583.9M582.2M

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving against Edwards Stock

  0.86SSY SunLink Health SystemsPairCorr
  0.69TFX Teleflex Incorporated Financial Report 2nd of May 2024 PairCorr
  0.65DYNT Dynatronics Financial Report 9th of May 2024 PairCorr
  0.65FIGS Figs Inc Financial Report 2nd of May 2024 PairCorr
  0.62NEOG Neogen Report 4th of April 2024 PairCorr
The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.
The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edwards Lifesciences Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.3
Revenue Per Share
9.897
Quarterly Revenue Growth
0.138
Return On Assets
0.1225
The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.